Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

IXJ vs JDOC overlap: 68% of top holdings shared

Bottom line

How much do IXJ and JDOC overlap?

68% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 58.7% of IXJ's assets and 63.9% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.

IXJ holds far more positions (124 vs 61), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

IXJJDOC
Weight overlap (top 25)68%
Shared holdings17
Weight in shared holdings58.7%63.9%
Total positions12461
Expense ratio0.38%0.65%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings IXJ and JDOC have in common

Holding% of IXJ% of JDOCOverlap
Eli Lilly And Company10.93%7.76%7.76%
Johnson & Johnson7.04%4.82%4.82%
Abbvie Inc.5.12%7.85%5.12%
Unitedhealth Group Incorporated4.40%5.85%4.40%
Merck & Co., Inc.4.12%4.82%4.12%
Astrazeneca Plc3.76%3.76%3.76%
Roche Holding AG3.75%2.82%2.82%
Novartis AG3.71%1.60%1.60%
Thermo Fisher Scientific Incorporated2.42%3.73%2.42%
Abbott Laboratories2.05%3.11%2.05%
Novo Nordisk A/s1.99%2.61%1.99%
Intuitive Surgical, Inc.1.83%1.93%1.83%
Cvs Health Corporation1.71%2.83%1.71%
Danaher Corporation1.56%2.16%1.56%
Bristol-myers Squibb Company1.53%3.57%1.53%
Stryker Corporation1.41%2.23%1.41%
Gsk Plc1.38%2.47%1.38%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in IXJ

  1. Amgen Inc. — 2.54%
  2. Gilead Sciences, Inc. — 2.04%
  3. Pfizer Inc. — 1.78%
  4. Vertex Pharmaceuticals Incorporated — 1.64%
  5. Medtronic Public Limited Company — 1.30%
  6. Sanofi Sa — 1.18%
  7. Mckesson Corporation — 1.18%
  8. Elevance Health, Inc. — 1.09%

Only in JDOC

  1. Cencora, Inc. — 2.07%
  2. Argenx SE — 2.06%
  3. Edwards Lifesciences Corp. — 1.73%
  4. IQVIA Holdings, Inc. — 1.71%
  5. Teva Pharmaceutical Industries Ltd. — 1.60%
  6. Regeneron Pharmaceuticals, Inc. — 1.60%
  7. Biogen, Inc. — 1.56%
  8. Cardinal Health, Inc. — 1.51%

Asset mix

Asset typeIXJJDOC
Stocks99.6%99.2%
Cash & short-term funds1.3%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryIXJJDOC
US70.6%75.2%
CH10.4%4.4%
GB5.8%6.2%
DK2.3%4.0%
JP3.7%2.5%
NL1.1%2.4%
FR2.0%—
DE1.6%1.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do IXJ and JDOC overlap?
About 68% by weight. 17 securities appear in both funds' top 25 holdings; they make up 58.7% of IXJ's assets and 63.9% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do IXJ and JDOC have in common?
The largest shared holdings are Eli Lilly And Company, Abbvie Inc., Johnson & Johnson, Unitedhealth Group Incorporated, Merck & Co., Inc..
Should I own both IXJ and JDOC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, IXJ or JDOC?
IXJ is broader, with 124 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.